Controlled Release Bone Morphogenic Protein/Nano-calcium

Information

  • Research Project
  • 6993258
  • ApplicationId
    6993258
  • Core Project Number
    R43DE017468
  • Full Project Number
    1R43DE017468-01
  • Serial Number
    17468
  • FOA Number
    PA-02-25
  • Sub Project Id
  • Project Start Date
    9/1/2005 - 21 years ago
  • Project End Date
    2/28/2007 - 19 years ago
  • Program Officer Name
    PANAGIS, JAMES S.
  • Budget Start Date
    9/1/2005 - 21 years ago
  • Budget End Date
    2/28/2007 - 19 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/22/2005 - 21 years ago
Organizations

Controlled Release Bone Morphogenic Protein/Nano-calcium

[unreadable] DESCRIPTION (provided by applicant): Controlled Release of Bone Morphogenic Protein using Nano-Calcium Phosphate Coatings TP-2004-71 We propose a novel method for depositing a drug-loaded coating based on a mixture of nano-phase calcium phosphate and bone morphogenic protein (BMP) on metal implants. One unique feature of the coating is that it will release the drug in a controlled fashion following the surgical procedure. Additionally, the coating is made up of nano-sized calcium phosphate features, which we have shown in preliminary studies to significantly enhance osteoblast function. In Phase I feasibility studies, three nano-calcium phosphate coating formulations (amorphous, semi- crystalline and crystalline) will be synthesized at Purdue University. Nano-phase calcium phosphate will then be mixed with BMP and coated onto titanium substrates using our novel deposition process. The coating on these samples will be evaluated for rate of release with the goal of reproducing our successful previous results from pelletized form of nano-CaPCVBMP material. After controlled rate of release has been demonstrated, we will assess protein bioactivity in vitro using osteoblast reactivity assay on nano-calcium phosphate material with and without BMP. Various structural and material characteristics of the coated samples will be studied using SEM, XRD, AFM and EDS. In Phase II, nano-CaPCVBMP coatings on implants will be evaluated in an in vivo animal model. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH
  • Activity
    R43
  • Administering IC
    DE
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    156878
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    121
  • Ed Inst. Type
  • Funding ICs
    NIDCR:156878\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SPIRE CORPORATION
  • Organization Department
  • Organization DUNS
    065137978
  • Organization City
    BEDFORD
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01730
  • Organization District
    UNITED STATES